| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |